Compare ULBI & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULBI | VANI |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.6M | 95.8M |
| IPO Year | 1995 | 2014 |
| Metric | ULBI | VANI |
|---|---|---|
| Price | $6.55 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 43.1K | ★ 190.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1166.67 | 14.00 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $164,456,000.00 | $4,000,000.00 |
| Revenue This Year | $31.30 | N/A |
| Revenue Next Year | $6.24 | N/A |
| P/E Ratio | $67.33 | ★ N/A |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $4.07 | $0.91 |
| 52 Week High | $9.51 | $1.92 |
| Indicator | ULBI | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 32.87 |
| Support Level | $5.52 | N/A |
| Resistance Level | $7.24 | $1.27 |
| Average True Range (ATR) | 0.38 | 0.05 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 89.01 | 14.29 |
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.